Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

PLT & Nektium Pharma Announce New Clinical Study on Zynamite® S Demonstrating Enhanced Non-Stim Mental Energy, Faster Information Processing and Improved Cognitive Performance


News provided by

PLT Health Solutions

Feb 27, 2025, 10:55 ET

Share this article

Share toX

Share this article

Share toX

New Water-Soluble, Taste-Neutral Form of Award-Winning Ingredient is Ideal for Beverages and Taste-Sensitive Formulations

MORRISTOWN, N.J., Feb. 27, 2025 /PRNewswire/ -- PLT Health Solutions, Inc announced the completion of a new clinical study by ingredient innovation partner Nektium Pharma (Gran Canaria) on a water-soluble addition to the award-winning Zynamite® ingredient family. In this study, a single 100 mg or 150 mg dose of Zynamite S showed a broad range of energy and performance benefits, including improved processing speed, improvements in complex task handling, improvements in mental flexibility, and enhanced mood. Both Zynamite and Zynamite S are patented, proprietary mango leaf (Mangifera indica) extracts standardized to ≥ 60% mangiferin. As a standalone or in combination with other ingredients, Zynamite has been shown to enhance mental energy and boost cognitive performance. Zynamite S allows formulators to confidently include this clinically studied, award-winning ingredient in beverages and other delivery systems where taste is an issue. PLT is the exclusive marketing partner of the Zynamite family of ingredients in North America and participates with Nektium in developing messaging on research results for US-based consumers.

Continue Reading
According to Joe Weiss, Global Head of Brand Management for PLT Health Solutions, Zynamite S is the latest innovation in a family of Zynamite ingredients that can bring an experiential response to beverage, food and supplement products. "Our customers asked us for a water-soluble form of the award-winning ingredient and our partner Nektium Pharma delivered.
According to Joe Weiss, Global Head of Brand Management for PLT Health Solutions, Zynamite S is the latest innovation in a family of Zynamite ingredients that can bring an experiential response to beverage, food and supplement products. "Our customers asked us for a water-soluble form of the award-winning ingredient and our partner Nektium Pharma delivered.
Zynamite offers rapid, sustained cognitive support relevant to target groups like students and working professionals. The enhanced cognitive function may help people tackle complex tasks and solve problems. Improved alertness, attention, and focus for up to 5 hours, can help people stay on track during classes, studying, or at work. Zynamite has also been shown to help manage tension and emotional discomfort, providing a sense of calm, even during demanding situations.
Zynamite offers rapid, sustained cognitive support relevant to target groups like students and working professionals. The enhanced cognitive function may help people tackle complex tasks and solve problems. Improved alertness, attention, and focus for up to 5 hours, can help people stay on track during classes, studying, or at work. Zynamite has also been shown to help manage tension and emotional discomfort, providing a sense of calm, even during demanding situations.

According to Joe Weiss, Global Head of Brand Management for PLT Health Solutions, Zynamite S is the latest innovation in a family of Zynamite ingredients that can bring an experiential response to beverage, food and supplement products. "Our customers asked us for a water-soluble form of the award-winning ingredient and our partner Nektium Pharma delivered. This ingredient dramatically changes the range of finished products that can include Zynamite, he said. "As a solutions provider, we see value in developing new clinical data on each product grade so our customers could bring innovation to consumers with confidence. Zynamite offers rapid, sustained cognitive support relevant to target groups like students and working professionals. The enhanced cognitive function may help people tackle complex tasks and solve problems. Improved alertness, attention, and focus for up to 5 hours, can help people stay on track during classes, studying, or at work. Zynamite has also been shown to help manage tension and emotional discomfort, providing a sense of calm, even during demanding situations. The rapid, sustained effects can contribute to extended focus and productivity sessions," he added.

New study shows broad-ranging benefits from a single dose

In the clinical study, 120 healthy university students were given a 100 mg or a 150 mg of Zynamite S or a matching placebo and then assessed three times over a 5-hour period (30 min, 3 hours, 5 hours). The study featured a randomized, double-blind, placebo-controlled crossover design with a 7-day washout between testing conditions.

Key findings from the new study included significant improvements in cognitive performance in the subjects taking Zynamite S, including

  • Improved processing speed
  • Increased focus and attention
  • Better cognitive flexibility and ability to manage complex tests
  • Elevated mood, reduced tension and enhanced energy
  • Acute effect (just one single dose)
  • Long-lasting effect after ingestion (up to 5 hours)

The latest study builds further on a comprehensive scientific body of evidence on Zynamite and confirms its potential to meet the demands of today's fast-paced lifestyles with non-stimulant energy and enhanced mental performance in a single low dose.

According to Dr. Laura Lopez, one of the study's researchers and Head of Product Research, Development & Innovation at Nektium, the study was designed to assess the effects of a low, single dose of Zynamite S on cognitive performance within a short time frame. "The results of this study certainly demonstrate that using Zynamite S is 'experiential.' Cognitive performance and mood improvements were shown over the course of a single morning in subjects undergoing a demanding battery of tests." Dr. Jeremy Appleton, Director of Medical & Scientific Affairs at PLT added, "These results will resonate with consumers who want to experience their benefits quickly. We are excited to have research on this new galenic form that delivers rapid, experiential benefits across many important domains of cognitive performance and mental well-being."

According to Steve Fink, PLT's Vice President of Marketing, the Zynamite S product form meets growing demand for ingredients that can add value to innovative energy, sports, hydration, and multiple benefit drinks. "Zynamite S is designed for use in applications such as RTDs and shots where solubility, neutral taste, heat stability, and transparency in solution are key," he said. "Botanical ingredients are often difficult to formulate, because of taste and solubility issues that can make them challenging for use in beverage formulations. Nektium is at the forefront in optimizing botanicals using smart delivery technology - this technology breakthrough for optimized performance in beverages will have a meaningful impact on the industry," he added.

To learn more about Zynamite S, visit us at Booth 3513 at NATURAL PRODUCTS EXPO WEST contact the company or visit the PLT website at www.plthealth.com/zynamite.

About PLT Health Solutions

Headquartered in Morristown, NJ, USA, PLT Health Solutions is a trusted discoverer, developer, and marketer of high-quality, scientifically supported ingredients that enhance health and functionality. As a leading ingredients innovator, PLT's global network of strategic partnerships provides unique access to impactful solutions. By delivering an unsurpassed mix of expertise, resources, and service, PLT is committed to helping both its strategic partners and valued customers grow.

About Nektium Pharma
Nektium Pharma, headquartered in Gran Canaria, Spain, is a leading developer of scientifically validated botanical extracts and natural ingredients, blending traditional ethnobotanical knowledge with cutting-edge research to create innovative, high-quality products for the health and wellness sector. With a strong focus on sustainability and clinical validation, Nektium delivers premium solutions that meet the global demand for natural, effective ingredients. It's flagship products include Zynamite®, Rhodiolife®, Xanthigen®, and Vanizem®.

Media Contact:
Mark Falconer
Sciencewerks
407-412-9705
E-mail: [email protected] 

Company Contact:
Steve Fink
PLT Health Solutions, Inc.
E-mail: [email protected]

SOURCE PLT Health Solutions

21%

more press release views with 
Request a Demo

Modal title

Also from this source

PLT and Nektium Announce New Clinical Study on Zynamite® S Ingredient that Redefines Non-Stim Mental Energy

PLT and Nektium Announce New Clinical Study on Zynamite® S Ingredient that Redefines Non-Stim Mental Energy

PLT Health Solutions, Inc. and innovation partner Nektium Pharma announced the completion of a new clinical study on its award-winning Zynamite® S...

PLT Health Solutions Unveils Second Clinical Study on Beverage-Friendly Dynagenix® Muscle+Joint Formula Demonstrating Enhanced Mobility & Rapid Joint Comfort within Five Days

PLT Health Solutions Unveils Second Clinical Study on Beverage-Friendly Dynagenix® Muscle+Joint Formula Demonstrating Enhanced Mobility & Rapid Joint Comfort within Five Days

PLT Health Solutions, Inc., in collaboration with Laila Nutraceuticals, today announced the completion of a second clinical study on its next...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Supplementary Medicine

Supplementary Medicine

Pharmaceuticals

Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.